Spotify 亿万富翁的全身扫描初创公司进军美国

Neko Health seems to be the hottest body scan in the world right now. The scan, co-founded by Spotify’s David Ek and Hjalmar Nilsonne, uses advanced technology to screen for issues in the blood, skin, and metabolism. Neko Health 似乎是目前全球最热门的全身扫描服务。该扫描服务由 Spotify 的 David Ek 和 Hjalmar Nilsonne 共同创立，利用先进技术筛查血液、皮肤和代谢方面的问题。

The company was founded in Sweden, has raised nearly $1 billion total, and just landed in New York. It has a global waitlist already topping 300,000 people, the company says. 该公司成立于瑞典，总融资额已接近 10 亿美元，并刚刚进驻纽约。据公司称，其全球候补名单人数已超过 30 万。

TechCrunch sat down with Farooq Abbasi of Preface Ventures, who invested in the company. He hopes Neko Health can be the future of preventative medicine, especially in a country like the United States, where the medical system is notoriously plagued with issues. TechCrunch 采访了曾投资该公司的 Preface Ventures 的 Farooq Abbasi。他希望 Neko Health 能成为预防医学的未来，特别是在像美国这样一个医疗体系因问题丛生而臭名昭著的国家。

Abbasi contends that preventative care utilization is low in the U.S. as people have concerns about how much it costs. Currently, Neko health charges $500 for its one-hour scan, which is not covered by insurance but should qualify as an acceptable expense for those that have Health Savings Accounts. “I think preventative care and healthcare should be cheap and accessible,” Abbasi said. Abbasi 认为，由于人们担心成本问题，美国的预防性医疗利用率很低。目前，Neko Health 的一小时扫描服务收费 500 美元，虽然保险不予报销，但对于拥有健康储蓄账户（HSA）的人来说，这应属于可接受的支出。Abbasi 表示：“我认为预防性护理和医疗保健应该是廉价且易于获取的。”

The hope is that Neko Health can tackle some of these issues, and it’s currently eyeing an expansion across the U.S. Abbasi has been scanned twice already and, perhaps, no surprise, says he loves it. “I think there should be Neko clinics everywhere,” he said. 人们希望 Neko Health 能解决其中一些问题，目前该公司正着眼于在美国全国范围内扩张。Abbasi 已经接受过两次扫描，不出所料，他表示非常满意。他说：“我认为到处都应该有 Neko 诊所。”

He says the product has grown so much since he first tried it. “In my generation one scan, it was a blood test with 15 biomarkers,” he said. “It was fifty-five this time.” 他表示，自他第一次尝试以来，该产品已经有了长足的进步。他说：“我第一次扫描时，血液检测包含 15 个生物标志物，而这次是 55 个。”

Neko also uses advanced computer vision for its scans and Abbasi sees this as another example of how AI is improving the medical sector overall. He argues that Neko Health isn’t just another wellness fad, but something that gives people “actionable insights to make their lives better,” he said. Neko 还利用先进的计算机视觉进行扫描，Abbasi 将此视为人工智能改善整个医疗行业的又一例证。他认为，Neko Health 不仅仅是又一个健康潮流，它还能为人们提供“改善生活的可操作性见解”。

Neko still has a long way to go in the U.S., especially on scaling and regulatory approval. But Abbasi is an optimist; he hopes more venture dollars will pour into the right companies and doesn’t think anything is too broken to fix. Neko 在美国仍有很长的路要走，特别是在规模化和监管审批方面。但 Abbasi 是个乐观主义者；他希望更多的风险投资能涌向正确的公司，并且不认为有什么问题是无法修复的。